Salazar et al. demonstrated that in a transgenic mice model of Alzheimer’s disease, PTK2B deletion improves deficits in memory and learning functions as well as synaptic loss [56]. The gene discussed is PTK2B; the disease is early-onset autosomal dominant Alzheimer disease.